Literature DB >> 8453963

Pharmacodynamic model of the haemodynamic effects of pinacidil in normotensive volunteers.

P Girard1, J L Saumet, F Dubois, J P Boissel.   

Abstract

The concentration-effect relationships of pinacidil, a peripheral vasodilator, have been measured in 12 healthy adults who received placebo or pinacidil 25 mg daily for 1 week in a cross-over experiment. Diastolic blood pressure (DBP) and heart rate (HR) were recorded and blood samples were taken on days 1 and 7. Plasma drug concentration-time data were fitted by a biexponential function with zero-order input. The pharmacokinetic model was incorporated into a combined pharmacokinetic-dynamic model (PK-PD) using the Hill equation, which has three parameters: n, the sigmoidicity parameter, Emax the maximum effect and EC50 the concentration which gives 50% of Emax. For delta DBP, the parameter medians were estimated as n = 5, EC50 = 44.6 ng.ml-1 and Emax = 13.5 mmHg. A hysteresis loop was found when delta HR was plotted against concentration, which could be fitted by a linear effect compartment model. Simulations showed that experimental delta DBP points on Day 7 could be predicted from a simulated curve computed by the model using parameters estimated on Day 1. Using the simulation, it was possible to suggest an optimal dosage regimen for pinacidil tablets.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8453963     DOI: 10.1007/bf00315477

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  26 in total

1.  HEREDITARY TRANSMISSION OF EXCEPTIONAL RESISTANCE TO COUMARIN ANTICOAGULANT DRUGS. THE FIRST REPORTED KINDRED.

Authors:  R A O'REILLY; P M AGGELER; M S HOAG; L S LEONG; M L KROPATKIN
Journal:  N Engl J Med       Date:  1964-10-15       Impact factor: 91.245

2.  Serum concentrations and urinary excretion of pinacidil and its major metabolite, pinacidil pyridine-N-oxide following i.v. and oral administration in healthy volunteers.

Authors:  A McBurney; P R Farrow; S Ainsworth; J W Ward
Journal:  Br J Clin Pharmacol       Date:  1985-01       Impact factor: 4.335

3.  Vascular effects in dogs of pinacidil (P 1134), a novel vasoactive antihypertensive agent.

Authors:  U B Olsen; E Arrigoni-Martelli
Journal:  Eur J Pharmacol       Date:  1983-04-08       Impact factor: 4.432

4.  Blood pressure and heart rate variabilities in normotensive and hypertensive human beings.

Authors:  G Mancia; A Ferrari; L Gregorini; G Parati; G Pomidossi; G Bertinieri; G Grassi; M di Rienzo; A Pedotti; A Zanchetti
Journal:  Circ Res       Date:  1983-07       Impact factor: 17.367

Review 5.  Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.

Authors:  N H Holford; L B Sheiner
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

6.  Evidence that the mechanism of the inhibitory action of pinacidil in rat and guinea-pig smooth muscle differs from that of glyceryl trinitrate.

Authors:  K M Bray; D T Newgreen; R C Small; J S Southerton; S G Taylor; S W Weir; A H Weston
Journal:  Br J Pharmacol       Date:  1987-06       Impact factor: 8.739

7.  Arterial vasodilating profile and biological effects of pinacidil in healthy volunteers.

Authors:  C Thuillez; E Pussard; E Bellissant; C Richer; R Kechrid; J F Giudicelli
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

8.  Pharmacokinetics and hypotensive effect in healthy volunteers of pinacidil, a new potent vasodilator.

Authors:  J W Ward; A McBurney; P R Farrow; P Sharp
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

9.  Pharmacokinetics and bioavailability of pinacidil capsules in human volunteers.

Authors:  M S Laher; M P Hickey
Journal:  J Int Med Res       Date:  1985       Impact factor: 1.671

10.  The influence of food intake on pharmacodynamics and plasma concentration of captopril.

Authors:  H M Müller; A Overlack; I Heck; R Kolloch; K O Stumpe
Journal:  J Hypertens Suppl       Date:  1985-11
View more
  1 in total

1.  Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.

Authors:  Christopher Louizos; Jaime A Yáñez; M Laird Forrest; Neal M Davies
Journal:  J Pharm Pharm Sci       Date:  2014       Impact factor: 2.327

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.